Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
N. Fouz Rosón (Barcelona, Spain). Effects of CPAP treatment on anxiety and depression in patients with OSAS. 2273

Member's Comments

No comment yet.

Related content which might interest you: Effect of CPAP adherence on depression in OSA patient Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020 The effects of anxiety and depression on treatment adherence in COPD patients Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Acute psychosis after CPAP treatment in a schizophrenic patient with sleep apnoea{-}hypopnoea syndrome Source: Eur Respir J 2001; 17: 313-315 Year: 2001 Insomnia, OSAS and CPAP treatment Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Effect of nCPAP-therapy to depressive symptoms in patients with obstructive sleep apnea Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010 Evaluation quality of life, anxiety, and depression in patients with obstructive sleep syndrome before and after three and twelve months of continuous positive airway pressure therapy Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 The effect of CPAP in asthma patients with SAHS Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021 Patients initial experiences of sleep apnea CPAP treatment Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care Year: 2018 Impact of pulmonary rehabilitation on anxiety and depression in patients with COPD Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008 Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Effects of CPAP treatment on 6MWD in OSAS and overlap syndrome patients Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 Do beta-blockers reduce sympathetic activity in patients with mild sleep breathing disorder without CPAP therapy? Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020 Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment Source: Eur Respir J 2007; 30: Suppl. 51, 335s Year: 2007 Biofeedback for panic disorder in patients with COPD Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Does persistent daytime hypersomnolence in CPAP treated patients with OSAS reflect comorbid narcolepsy or restless legs syndrome ? Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2011; 39: 227-228 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2011; 39: 226-227 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2012; 39: 226-227 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2012; 39: 227-228 Year: 2012